The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty
- PMID: 23599045
- DOI: 10.1152/ajpgi.00035.2013
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty
Abstract
Rapid degradation of glucagon-like peptide-1 (GLP-1) by dipeptidyl peptidase-4 suggests that endogenous GLP-1 may act locally before being degraded. Signaling via the vagus nerve was investigated in 20 truncally vagotomized subjects with pyloroplasty and 10 matched healthy controls. Subjects received GLP-1 (7-36 amide) or saline infusions during and after a standardized liquid mixed meal and a subsequent ad libitum meal. Despite no effect on appetite sensations, GLP-1 significantly reduced ad libitum food intake in the control group but had no effect in the vagotomized group. Gastric emptying was accelerated in vagotomized subjects and was decreased by GLP-1 in controls but not in vagotomized subjects. Postprandial glucose levels were reduced by the same percentage by GLP-1 in both groups. Peak postprandial GLP-1 levels were approximately fivefold higher in the vagotomized subjects. Insulin secretion was unaffected by exogenous GLP-1 in vagotomized subjects but was suppressed in controls. GLP-1 significantly reduced glucagon secretion in both groups, but levels were approximately twofold higher and were nonsuppressible in the early phase of the meal in vagotomized subjects. Our results demonstrate that vagotomy with pyloroplasty impairs the effects of exogenous GLP-1 on food intake, gastric emptying, and insulin and glucagon secretion, suggesting that intact vagal innervation may be important for GLP-1's actions.
Trial registration: ClinicalTrials.gov NCT01176890.
Keywords: DPP-4; GLP-1; degradation; insulin and glucagon secretion; meal test; vagotomy; vagus nerve.
Similar articles
-
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?J Clin Endocrinol Metab. 2010 May;95(5):2367-75. doi: 10.1210/jc.2009-2133. Epub 2010 Mar 1. J Clin Endocrinol Metab. 2010. PMID: 20194711 Clinical Trial.
-
Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.Eur J Endocrinol. 2013 Jul 6;169(2):187-201. doi: 10.1530/EJE-13-0264. Print 2013 Aug. Eur J Endocrinol. 2013. PMID: 23704713 Free PMC article. Clinical Trial.
-
Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy.Physiol Behav. 2015 Feb;139:167-76. doi: 10.1016/j.physbeh.2014.11.031. Epub 2014 Nov 15. Physiol Behav. 2015. PMID: 25449395
-
Is glucagon-like peptide 1 an incretin hormone?Diabetologia. 1999 Mar;42(3):373-9. doi: 10.1007/s001250051165. Diabetologia. 1999. PMID: 10096792 Review.
-
Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.Diabetes Obes Metab. 2016 Mar;18(3):224-35. doi: 10.1111/dom.12593. Epub 2016 Jan 5. Diabetes Obes Metab. 2016. PMID: 26500045 Review.
Cited by
-
State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis.Res Sq [Preprint]. 2024 Mar 12:rs.3.rs-3929981. doi: 10.21203/rs.3.rs-3929981/v1. Res Sq. 2024. PMID: 38559032 Free PMC article. Preprint.
-
Evaluating the effectiveness and underlying mechanisms of incretin-based treatments for hypothalamic obesity: A narrative review.Obes Pillars. 2024 Feb 24;10:100104. doi: 10.1016/j.obpill.2024.100104. eCollection 2024 Jun. Obes Pillars. 2024. PMID: 38463533 Free PMC article. Review.
-
Enteroendocrine cell regulation of the gut-brain axis.Front Neurosci. 2023 Nov 7;17:1272955. doi: 10.3389/fnins.2023.1272955. eCollection 2023. Front Neurosci. 2023. PMID: 38027512 Free PMC article. Review.
-
Carbohydrate-insulin model: does the conventional view of obesity reverse cause and effect?Philos Trans R Soc Lond B Biol Sci. 2023 Oct 23;378(1888):20220211. doi: 10.1098/rstb.2022.0211. Epub 2023 Sep 4. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37661740 Free PMC article. Review.
-
Plasma glucagon-like peptide-2 concentrations are lower in dogs with chronic enteropathies than in healthy dogs.Am J Vet Res. 2023 Sep 5;84(11):ajvr.23.06.0149. doi: 10.2460/ajvr.23.06.0149. Print 2023 Nov 1. Am J Vet Res. 2023. PMID: 37657734 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources